Ars Pharmaceuticals Inc (SPRY)
Retained Earnings
-$417.56M
Quarterly · Period ending: · USD
SPRY Retained Earnings
Latest reported-$417.56Mperiod ending
Latest reported-$417.56Mperiod ending
SPRY Quarterly Retained Earnings (-$63.79M → -$417.56M)
Quarterly retained earnings
High-resolution chart · PNG
SPRY retained earnings history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Retained Earnings (USD) |
|---|---|
| -417,560,000 | |
| -355,221,000 | |
| -294,603,000 | |
| -253,279,000 | |
| -202,128,000 | |
| -157,245,000 | |
| -123,305,000 | |
| -173,239,000 | |
| -154,111,000 | |
| -141,595,000 | |
| -131,303,000 | |
| -124,135,000 | |
| -109,269,000 | |
| -91,899,000 | |
| -76,938,000 | |
| -62,509,000 | |
| -55,926,000 | |
| -210,843,000 | |
| -42,256,000 | |
| -162,752,000 | |
| -140,097,000 | |
| -115,601,000 | |
| -96,734,000 | |
| -63,787,000 |